Ratings
0
Nobody has rated this yet. Be the first!
Works
2
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma
